Rachael N. McVicar

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Thomas Mandel Clausen, Daniel R. Sandoval, Charlotte B. Spliid et al. · Cell · 2020 · 1.2K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory Syndrome

Hratch Baghdassarian, Sarah A. Blackstone, Rachael L. Philips et al. · New England Journal of Medicine · 2023 · 77 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs

Robert T. Schooley, Aaron F. Carlin, James R. Beadle et al. · Antimicrobial Agents and Chemotherapy · 2021 · 73 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Generation of Complete Multi−Cell Type Lung Organoids From Human Embryonic and Patient‐Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation

Sandra L. Leibel, Rachael N. McVicar, Alicia M. Winquist et al. · Current Protocols in Stem Cell Biology · 2020 · 69 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Rethinking Remdesivir: Synthesis, Antiviral Activity and Pharmacokinetics of Oral Lipid Prodrugs

Robert T. Schooley, Aaron F. Carlin, James R. Beadle et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17